Patients Stopping Slimming Medications Gain Back Weight Four Times Faster Than Dieters

Fresh analysis reveals that patients who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Findings released in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the mass is regained at an average rate of 0.8 kg per month once they quit.

"People using these drugs need to be aware of the potential of rapid weight regain when the treatment ends," warns researcher Dr. Susan Jebb.

This pace of recovery means a return to starting weight in about 18 months.

Comparing Therapies

The study, which examined dozens of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.

The team note that people who lose weight through diet and exercise usually have a less rapid creep back—approximately 100 grams monthly—after stopping.

Explaining the Rapid Regain

Experts propose the way of the drugs accounts for the amplified rebound.

These medications copy a body's own chemical called GLP-1, which helps regulate hunger.

"Long-term administration of GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication results in hunger is unsuppressed, making excessive eating much more probable."

A Chronic Disease?

Health authorities suggest the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts say that, given the significant potential of weight regain, the treatment might need to be life-long.

This view is echoed by drug manufacturers, who state that the findings "emphasize the long-term nature of excess weight," comparing it to managing diseases like hypertension.

User Testimonies

People who have stopped the jabs explain a sudden resurgence of hunger.

"It was like a trigger flipping and I was suddenly starving," described one woman.

The struggle is worsened if individuals have not adopted permanent lifestyle or habit modifications during treatment.

Growing Interest

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Use is greater among women than males.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

Finally, experts stress that while these medications are powerful agents for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on ongoing lifestyle management.